Cargando…
Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications
Breast cancer has been the leading cause of female cancer deaths for decades. Intratumoral hypoxia, mainly caused by structural and functional abnormalities in microvasculature, is often associated with a more aggressive phenotype, increased risk of metastasis and resistance to anti-malignancy treat...
Autores principales: | Zhang, Ying, Zhang, Hongyi, Wang, Minghong, Schmid, Thomas, Xin, Zhaochen, Kozhuharova, Lora, Yu, Wai-Kin, Huang, Yuan, Cai, Fengfeng, Biskup, Ewelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991906/ https://www.ncbi.nlm.nih.gov/pubmed/33777815 http://dx.doi.org/10.3389/fonc.2021.652266 |
Ejemplares similares
-
The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer
por: Yong, Liyun, et al.
Publicado: (2022) -
Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022) -
Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021) -
Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
por: Cai, Fengfeng, et al.
Publicado: (2019) -
Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications
por: Wang, Hui, et al.
Publicado: (2021)